NCT01692483View on ClinicalTrials.gov

Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Prostate Neoplasms
Interventions
DRUG

Abiraterone acetate

Abiraterone 1000 mg (4 x 250 mg tablets) taken orally once daily

DRUG

Prednisone

Prednisone or prednisolone 5 mg tablet taken orally twice daily

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutica

INDUSTRY